Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 7/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.32 |
| ▸ | SMO | Q99835 | 1/20 | 0.31 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14889057 | 0.78 | SMO (0.36) | NR3C1CYP11B1CYP11B2PGRMAP4K1 | |
| SCHEMBL14889065 | 0.76 | MAT2A (0.33) | GPR119 | |
| SCHEMBL1701230 | 0.72 | CHEK1 (0.46) | NR3C1CYP11B1CYP11B2 | |
| SCHEMBL1701337 | 0.68 | KDR (0.50) | — | |
| SCHEMBL1701255 | 0.68 | GABRP (0.41) | NR3C1 | |
| SCHEMBL15946508 | 0.68 | MEN1 (0.34) | NR3C1CYP11B1CYP11B2PGRMAP4K1 | |
| SCHEMBL13486145 | 0.66 | NR3C1 (0.61) | NR3C1CYP11B1CYP11B2PGRSMO | |
| SCHEMBL1701940 | 0.65 | PDE10A (0.38) | NR3C1SMO | |
| SCHEMBL22225746 | 0.61 | NR3C1 (0.74) | NR3C1CYP11B1CYP11B2PGR | |
| SCHEMBL22199134 | 0.60 | NR3C1 (0.57) | NR3C1CYP11B1CYP11B2PGRSMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103153995-A | Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors | TAKEDA PHARMACEUTICAL | 2013-06-12 | — | — | CN | disclosed |
| EP-2585462-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS | Takeda Pharmaceutical Company Limited (JP) | 2013-05-01 | — | — | EP | disclosed |